ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 9,600.00
+2,210.00 (29.91%)
At close: Apr 23, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 229.59 billion as of April 24, 2026. Its market cap has increased by 314.57% in one year.
Market Cap
229.59B
Enterprise Value
192.30B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,600.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 229.59B, a decrease of -59.09%. That is a compound annual growth rate of -17.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 229.59B | 14.87% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 212.50B |
| ISU Abxis | 197.53B |
| Prestige Biologics | 192.83B |
| Ensol Biosciences | 190.59B |
| QuadMedicine | 147.89B |
| CORESTEMCHEMON | 141.07B |
| BIO-FD&C | 123.74B |
| NovMetaPharma | 122.64B |